Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 68,466,072
  • Shares Outstanding, K 269,732
  • Annual Sales, $ 15,983 M
  • Annual Income, $ 311,000 K
  • 60-Month Beta 1.12
  • Price/Sales 4.28
  • Price/Cash Flow 13.92
  • Price/Book 3.21

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 3.07
  • Number of Estimates 13
  • High Estimate 3.20
  • Low Estimate 2.96
  • Prior Year 2.91
  • Growth Rate Est. (year over year) +5.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
239.36 +4.80%
on 06/20/19
256.28 -2.12%
on 07/12/19
+12.60 (+5.29%)
since 06/19/19
3-Month
221.47 +13.26%
on 05/15/19
256.28 -2.12%
on 07/12/19
+22.95 (+10.07%)
since 04/18/19
52-Week
208.62 +20.24%
on 12/26/18
265.87 -5.65%
on 10/01/18
+3.86 (+1.56%)
since 07/19/18

Most Recent Stories

More News
IVD Market Sustains Momentum: 3 Stocks in Focus

In-vitro Diagnostics has successfully proven itself to be the best diagnostic procedures. So, investors can add stocks from this space to their watchlist.

ABT : 87.49 (-0.31%)
TMO : 289.82 (-1.33%)
BDX : 250.84 (-1.18%)
BIO : 315.18 (+1.65%)
RHHBY : 33.6401 (-2.41%)
BD Provides Update on Voluntary Recalls of Alaris(TM) Pump Module Model 8100 and Certain Alaris(TM) Pump Infusion Sets

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls related to certain Alaris(TM) Pump Modules Model 8100 manufactured...

BDX : 250.84 (-1.18%)
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2019 earnings conference call on Tuesday, August 6, 2019, at 8:00 a.m. (ET)....

BDX : 250.84 (-1.18%)
Nuvasive Inc has the Best Relative Performance in the Health Care Equipment Industry (NUVA , BDX , GMED , RMD , SYK )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

GMED : 42.63 (-1.11%)
NUVA : 58.12 (-0.07%)
BDX : 250.84 (-1.18%)
Best Relative Performance in the Health Care Equipment Industry Detected in Shares of Becton Dickinson (BDX , VAR , BAX , IDXX , IART )

Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...

VAR : 132.80 (-1.89%)
BDX : 250.84 (-1.18%)
BAX : 83.10 (+0.02%)
BD Statement on FDA Circulatory System Devices Panel Regarding Paclitaxel-Coated Devices

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement following the U.S. Food and Drug Administration (FDA) Circulatory System...

BDX : 250.84 (-1.18%)
Watch for Becton Dickinson to Potentially Pullback After Gaining 1.63% Yesterday

Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $240.02 to a high of $243.48. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

BDX : 250.84 (-1.18%)
Becton Dickinson Rises 1.63% on Heavy Volume: Watch For Potential Pullback

Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $240.02 to a high of $243.48. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

BDX : 250.84 (-1.18%)
Why Is Becton Dickinson (BDX) Up 3.7% Since Last Earnings Report?

Becton Dickinson (BDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BDX : 250.84 (-1.18%)
SmarTrend Watching for Potential Pullback in Shares of Becton Dickinson After 1.26% Gain

Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $237.80 to a high of $238.26. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of...

BDX : 250.84 (-1.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BDX with:

Business Summary

Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories....

See More

Key Turning Points

2nd Resistance Point 255.35
1st Resistance Point 253.09
Last Price 250.84
1st Support Level 249.65
2nd Support Level 248.46

See More

52-Week High 265.87
Last Price 250.84
Fibonacci 61.8% 244.00
Fibonacci 50% 237.24
Fibonacci 38.2% 230.49
52-Week Low 208.62

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar